Prostate cancer is the most common cancer among men in many countries — including Sweden, the UK, and the United States. While it often grows slowly and without symptoms, aggressive forms can spread rapidly and become life-threatening if not caught early.

This comprehensive guide covers everything you need to know about prostate cancer: what it is, how it develops, early warning signs, risk factors, modern detection methods like the Stockholm3 test, and available treatment options.

Prostate cancer is the most common cancer among men in many countries — including Sweden, the UK, and the United States. While it often grows slowly and without symptoms, aggressive forms can spread rapidly and become life-threatening if not caught early.

This comprehensive guide covers everything you need to know about prostate cancer: what it is, how it develops, early warning signs, risk factors, modern detection methods like the Stockholm3 test, and available treatment options.

Prostate cancer is the most common cancer among men in many countries, including Sweden. It’s a disease that often develops quietly, with few or no symptoms in its early stages. That’s one of the reasons why so many cases go undetected until the cancer has progressed – and why understanding the symptoms of prostate cancer can literally be life-saving.

Prostate cancer is the most common cancer among men in many countries and one of the leading causes of cancer-related deaths. However, the good news is that when it’s found early, it’s also one of the most treatable. The challenge? In its early stages, prostate cancer often doesn’t cause any symptoms.

Prostate cancer is the most common cancer in men in many parts of the world. In countries like Sweden, thousands of men are diagnosed every year — some with slow-growing tumors, others with aggressive forms that require immediate treatment.

But why do some men develop prostate cancer while others don’t?

This article explores the key risk factors for prostate cancer, what the latest research says, and how you can take steps to reduce your risk.

For decades, the primary tool for prostate cancer screening has been the PSA test – a simple blood test that measures a protein produced by the prostate gland. While PSA testing has saved lives by helping to detect cancer early, it also comes with well-known limitations: false positives, unnecessary biopsies, and overdiagnosis of low-risk cancers.